Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients *

Journal of Neural Transmission

Volumn 112, Issue 5, 2005, Pages 677-692

  Plotkin, M ^a   Amthauer, H ^a   Klaffke, S ^a   Kuhn A ^a   Ludemann L ^a   Arnold, G ^a   Wernecke, K D ^a   Kupsch, A ^a   Felix, R ^a   Venz, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

123 I FP CIT; 123 I IBZM; Parkinsonian syndromes; Single photon emission tomography (SPECT)

Indexed keywords

2BETA CARBOMETHOXY 3BETA 4 IODOPHENYL TROPANE I 123; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; IODOBENZAMIDE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; 3 IODO 2 HYDROXY 6 METHOXY N ((1 ETHYL 2 PYRROLIDINYL)METHYL)BENZAMIDE; 3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE; BENZAMIDE DERIVATIVE; PYRROLIDINE DERIVATIVE; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ESSENTIAL TREMOR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECEPTOR BINDING; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; BENZAMIDES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 17844398549     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0208-x     Document Type: Article

References (49)

1. Ahlskog JE (2001) Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. Parkinsonism Relat Disord 7: 63-67
2. Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brücke T (1998) [123I] beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 105: 1213-1228
3. Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E et al. (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT SPECT study group. Mov Disord 15: 503-510
4. Bettin S, Kämpfer I, Seese A, Schäfer A, Reuter M, Lößner J et al. (1997) Striatal uptake of I-123-β-CIT and I-123-IBZM in patients with extrapyramidal symptoms. Nuklearmedizin 36: 167-172
5. Booij J, Speelman JD, Hornstink MWIM, Wolters EC (2001) The clinical benefit of imaging striatal dopamine transporters with [123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 28: 266-272
6. Brooks DJ (1993) PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 43 [Suppl 6]: 6-16
7. 11C-raclopride and positron emission tomography. Ann Neurol 31: 184-192
8. Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wober C et al. (1997) Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm [Suppl] 50: 9-24
9. Byrne EJ, Lennox G, Godwin-Austen RB, Lowe J, Mayer RJ et al. (1991) Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 2: 283-284
10. Chang L (1978) A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 25: 638-643
11. Dubinsky RM, Jankovic J (1987) Progressive supranuclear palsy and a multi-infarct state. Neurology 37: 570-576
12. Frisoni GB, Pizzolato G, Zanetti O, Bianchetti A, Chierichetti F, Trabucchi M (1995) Corti-cobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol 35: 50-54
13. Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112: 1171-1192
14. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Flower CJ et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163: 94-98
15. Grasser T (2003) Overview of the genetics of parkinsonism. Adv Neurol 91: 143-152
16. Habraken JB, Booij J, Slomka P, Sokole EB, van Royen EA (1999) Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 40: 1091-1097
17. Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W et al. (1998) Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. J Nucl Med 39: 954-960
18. Hoeffken H, Gerstner A, Bayraktar M, Gotthardt M, Schipper ML, Schlieck A, Gratz S, Oertel T, Behr M et al. (2002) Prospective evaluation of combined I-123 FP-CIT and I-123 IBZM SPECT in the differential diagnosis of Parkinson's syndrome. J Nucl Med 43: 62
19. Hughes AJ, Lees AJ, Stern GM (1991) Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 41: 1723-1725
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
21. Jankovic J, Rajput AH, McDermott MP, Perl DP (2000) The evolution of diagnosis in parkinsonism: a prospective study. Arch Neurol 57: 369-372
22. Kim GM, Kim SE, Lee WY (2000) Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: studied with [(123)I]beta-CIT and SPECT. Eur Neurol 43: 23-29
23. Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Taschida T et al. (2002) Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA and PSP. Mov Disord 17: 303-312
24. Larisch R, Klimke A (1998) On the clinical impact of cerebral dopamine D2 receptor scintigraphy. Nuklearmedizin 37: 245-250
25. Litvan I (2001) Diagnosis and management of progressive supranuclear palsy. Semin Neurol 21: 41-48
26. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski-syndrome): report of the NINDS-SPSP International Workshop. Neurology 47: 1-9
27. Litvan I, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18: 467-486
28. McKeith IG, Perry RH, Faibairn AF, Jabeen S, Perry EK (1994) Operational criteria for senile dementia of Lewy body type (SDLT). Pathol Med 22: 911-922
29. Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brucke T et al. (1997) Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease. J Nucl Med 38: 1711-1717
30. Pirker W, Asenbaum S, Bencsits C, Prayer D, Gerschlager W, Deecke L et al. (2000) [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration. Mov Disord 15: 1158-1167
31. Rajput AH, Rozdilsky B, Ang L, Rajput A (1991) Clinicopathological observations in essential tremor: report of six cases. Neurology 41: 1422-1424
32. Rajput AH, Rozdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in parkinsonism - prospective study. Can J Neurol Sci 18: 275-278
33. Ransmayr G, Seppi K, Donnemiller E, Luginger E, Marksteiner J, Riccabona G et al. (2001) Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease. Eur J Nucl Med 28: 1523-1528
34. Rice JE, Thompson PD (2001) Movement disorders. I. Parkinsonism and the akinetic-rigide syndromes. Med J Aust 174: 357-363
35. Riley DE, Lang AE, Lewis A, Resch L, Ashby P, Hornykiewicz O, Black S (1990) Corticobasal degeneration. Neurology 40: 1203-1212
36. Rohlfing T, West JB, Beier J, Liebig T, Taschner CA, Thomale UW (2000) Registration of functional and anatomical MRI: accuracy assessment and application in navigated neurosurgery. Comput Aided Surg 5: 414-425
37. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS (1997) Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48: 959-969
38. Schwarz J, Tatsch K, Arnold G, Ott M, Trenkwalder C, Kirsch CM et al. (1993) 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 43: 17-20
39. Schwarz J, Tatsch K, Gasser T, Arnold G, Pogarell O, Künig G et al. (1998) 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Mov Disord 13: 16-19
40. Studholme C, Hill DL, Hawkes DJ (1997) Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys 24: 25-35
41. Tatsch K (2001) Imaging of the dopaminergic system in parkinsonism with SPET. Nucl Med Commun 22: 819-827
42. 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. J Nucl Med Commun 12: 699-707
43. Terashi H, Nagata K, Hirata Y, Hatazawa J, Utsumi H (2001) Study on dopamine D2 binding capacity in vascular parkinsonism. Rinsho Shinkeigaku 41: 659-664
44. Van Royen E, Verhoeff NP, Speelman JD, Wolters EC, Kuiper MA, Janssen AG (1993) Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission tomography. Arch Neurol 50: 513-551
45. Varrone A, Innis RB, Marek K, Zoghbi S, Baldwin R, Seibyl JP (1998) Evaluation of patients with parkinsonism with [123]IBF and β-CIT SPECT. J Nucl Med 39: 14P
46. 123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 16: 1023-1029
47. Walker Z, Costa DC, Janssen AG, Walker RWH, Livingstone G, Katona CLE (1997) Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. Eur J Nucl Med 24: 609-614
48. Wenning GK, Donnemiller E, Granata R, Riccabona G, Poewe W (1998) 123I-beta-CIT and 123I-IBZM SPECT scanning in levodopa naive Parkinson's disease. Mov Disord 13: 438-445
49. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577